Lilly became a $1T company without using any AI for the discovery of their blockbuster drugs. With AI they could easily 10X that valuation.
Nvidia and Eli Lilly are building a $1B lab for AI drug discovery in SF.
Lilly CEO Dave Ricks talks about their data advantage: “Some scale [tech-bio] players…are just training on public data but they’re only 4,000 ever approved drugs. Lilly alone has 3 million failed drugs.”












